ETF Holdings Breakdown of HRMY

Stock NameHarmony Biosciences Holdings
TickerHRMY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS4131971040

News associated with HRMY

Needham & Company LLC Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY)
Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $49.00 target price on the stock. Needham & Company LLC’s price target suggests a potential upside of 46.44% from the stock’s previous close. […] - 2025-05-08 07:40:44
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up Following Better-Than-Expected Earnings
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report)’s share price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $29.96, but opened at $31.11. Harmony Biosciences shares last traded at $31.61, with a volume of 147,182 shares changing hands. The company reported […] - 2025-05-08 05:25:26
Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $52.44
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in […] - 2025-05-05 05:49:06
Barclays PLC Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Barclays PLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 31.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,872 shares of the company’s stock after purchasing an additional 24,010 shares during the […] - 2025-04-29 08:22:55
UBS Group Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price
Harmony Biosciences (NASDAQ:HRMY – Free Report) had its price target lowered by UBS Group from $55.00 to $48.00 in a research note released on Monday, MarketBeat.com reports. UBS Group currently has a buy rating on the stock. A number of other equities analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on […] - 2025-04-29 07:28:55
Envestnet Asset Management Inc. Raises Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Envestnet Asset Management Inc. raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 53,826 shares of the company’s stock after buying an additional 1,321 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Harmony Biosciences were worth $1,852,000 at […] - 2025-04-28 07:37:03
Legal & General Group Plc Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Legal & General Group Plc lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 27.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 116,959 shares of the company’s stock after buying an additional 25,338 shares during […] - 2025-04-23 08:19:04
Geode Capital Management LLC Has $31.08 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Geode Capital Management LLC raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 22.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 902,934 shares of the company’s stock after buying an additional 167,516 shares during the […] - 2025-04-17 07:53:09
Franklin Resources Inc. Has $1.10 Million Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Franklin Resources Inc. boosted its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 7.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,869 shares of the company’s stock after buying an additional 2,096 shares during […] - 2025-04-16 08:11:07
Norges Bank Makes New $16.12 Million Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Norges Bank bought a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor bought 468,410 shares of the company’s stock, valued at approximately $16,118,000. A number of other hedge funds have also made changes to their positions in the stock. JPMorgan Chase & […] - 2025-04-08 07:50:56
Arrowstreet Capital Limited Partnership Sells 20,948 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Arrowstreet Capital Limited Partnership reduced its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 6.6% in the 4th quarter, Holdings Channel reports. The firm owned 296,618 shares of the company’s stock after selling 20,948 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Harmony Biosciences were worth $10,207,000 as of its […] - 2025-04-06 08:28:53
Teacher Retirement System of Texas Buys 3,964 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Teacher Retirement System of Texas boosted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 50.6% in the fourth quarter, HoldingsChannel reports. The firm owned 11,801 shares of the company’s stock after acquiring an additional 3,964 shares during the period. Teacher Retirement System of Texas’ holdings in Harmony Biosciences were worth $406,000 […] - 2025-04-01 08:51:08
23,000 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Acquired by KLP Kapitalforvaltning AS
KLP Kapitalforvaltning AS purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 23,000 shares of the company’s stock, valued at approximately $791,000. Several other large investors have also recently modified […] - 2025-04-01 08:14:57
Amundi Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Amundi raised its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 243.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 18,402 shares of the company’s stock after buying an additional 13,041 shares during the quarter. Amundi’s holdings in Harmony Biosciences were worth $635,000 as of its most […] - 2025-03-21 08:39:12
Mizuho Raises Harmony Biosciences (NASDAQ:HRMY) Price Target to $44.00
Harmony Biosciences (NASDAQ:HRMY – Get Free Report) had its price target lifted by equities research analysts at Mizuho from $42.00 to $44.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s target price points to a potential upside of 27.91% from the stock’s […] - 2025-03-20 06:48:59
Handelsbanken Fonder AB Boosts Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Handelsbanken Fonder AB lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 19.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,500 shares of the company’s stock after acquiring an additional 2,200 shares during the […] - 2025-03-03 08:52:53
Harmony Biosciences (NASDAQ:HRMY) Receives “Buy” Rating from Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research report report published on Tuesday,Benzinga reports. The firm currently has a $50.00 price target on the stock. Several other equities research analysts have also weighed in on the company. Deutsche Bank Aktiengesellschaft initiated coverage on […] - 2025-02-26 08:56:55
New York State Teachers Retirement System Has $1.09 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
New York State Teachers Retirement System raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,693 shares of the company’s stock after buying an additional 809 shares during the period. New York State Teachers Retirement System’s holdings in Harmony Biosciences […] - 2025-02-24 08:57:05
Needham & Company LLC Cuts Harmony Biosciences (NASDAQ:HRMY) Price Target to $50.00
Harmony Biosciences (NASDAQ:HRMY – Get Free Report) had its price target cut by stock analysts at Needham & Company LLC from $52.00 to $50.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s target price points to a potential upside […] - 2025-02-21 08:18:53
HC Wainwright Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY)
HC Wainwright reissued their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a report published on Wednesday,Benzinga reports. The firm currently has a $75.00 price target on the stock. A number of other equities analysts have also commented on the company. Needham & Company LLC cut their price target on Harmony […] - 2025-02-20 09:36:56
Brokerages Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) PT at $55.00
Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) have earned an average rating of “Buy” from the nine analysts that are covering the company, Marketbeat reports. Nine research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have issued a report on the […] - 2025-02-19 07:04:53
Harmony Biosciences (NASDAQ:HRMY) Research Coverage Started at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research note released on Tuesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $55.00 target price on the stock. A number of other research firms have also recently commented on HRMY. HC Wainwright reissued a “buy” […] - 2025-02-14 08:32:51

HRMY institutional holdings

The following institutional investment holdings of HRMY have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 31,880USD 1,086,789
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 4,217USD 143,758 1.9%
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 49,689USD 1,693,898 1.9%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 26,882USD 916,407
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 26,882USD 916,407 1.9%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 136USD 4,636 1.9%
Total =139,686 USD 4,761,895
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.